Smokeless tobacco: Risk factor for cardiovascular and breathing in young Indian adolescent

Choudhary, Arbind Kumar; Qudeer, A.

doi:10.1016/j.hipert.2019.03.002

Cited by 4 publications

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Participants were made aware of the same during the oral examination and were briefed about the consequences. Smokeless tobacco users have high rates of mucosal pathology [ 24 ].…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of Behavioral Counseling in Smokeless Tobacco Cessation Among Adult Users Reporting to a Dental Hospital in Pune: A Randomized Controlled Trial

Kumbhalwar¹,

Hegde²,

Kakodkar³

et al. 2022

Cureus

View full text Add to dashboard Cite

Aim To assess the effectiveness of behavioral counseling for smokeless tobacco cessation among adult users in a dental hospital setting. Methods A total of 200 patients visiting a dental hospital who were exclusively using smokeless tobacco (SLT) were enrolled in the study. A randomized controlled trial with a concurrent parallel study design, which consisted of two arms, was conducted. Fagerstrom test for nicotine dependence level and the transtheoretical stage of change was assessed at the baseline. Behavioral cessation counseling and motivational interviewing were provided in the study arm and brief advice was given to those in the control arm. The counseling was provided at baseline and followed up till six months through telephone to assess the change in the frequency of use of SLT products and abstinence from SLT use. A biochemical validation with a urine cotinine test was done to confirm abstinence. Results At six months, there was a significant difference within and between the study and control groups, indicating the role played by behavioral tobacco cessation in reducing the frequency of consumption. About 24.4% of participants in the study group and 10% in the control group abstained from the habit at the sixth month, with an odd’s ratio (OR)=2.91 and with a loss to follow-up of 10% in each of the groups. The cotinine test, which was used for validation, revealed a significant difference between the study and the control group. The number needed to treat (NNT) shows that to motivate one additional person to give up the SLT habit, we need to intervene with about seven people. Conclusion Behavior intervention with motivational interviewing was considered an effective method in promoting smokeless tobacco cessation among adults. Transtheoretical stages of change have proven to be an effective model to assess the stage of behavior change of the population toward SLT use and was also helpful for changing the behavior.

show abstract

“…Participants were made aware of the same during the oral examination and were briefed about the consequences. Smokeless tobacco users have high rates of mucosal pathology [ 24 ].…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of Behavioral Counseling in Smokeless Tobacco Cessation Among Adult Users Reporting to a Dental Hospital in Pune: A Randomized Controlled Trial

Kumbhalwar¹,

Hegde²,

Kakodkar³

et al. 2022

Cureus

View full text Add to dashboard Cite

show abstract

“…Thus this study shows that SLT adversely affects the cardiovascular parameters increasing the risk of cardiovascular disease. 26 Another study conducted on sub-Saharan women SLT user found higher differential blood pressure. 27 Similarly, an Indian study evaluating the inflammatory and thrombotic markers in SLT user found significantly higher levels of IL-6, tumor necrosis factor (TNF)-α, fibrinogen, and D-dimer.…”

Section: Smokeless Tobacco and Cardiovascular Diseasesmentioning

confidence: 97%

Smokeless Tobacco and Its Ill-Effects: Recent Literature Update

Singhavi

Singh

Chaturvedi

2021

Indian J Med Paediatr Oncol

View full text Add to dashboard Cite

According to the Global Adult Tobacco Survey part 2 (GATS-2), approximately 200 million adult Indians consume smokeless tobacco (SLT). Circumvention of SLT product ban has been observed. We conducted a review of the literature to summarize the ill effects of tobacco for the articles published from 2019 to 2020. A systematic search of the databases PubMed (2019 onward) and Web of Science (2019 onward), through February 2021 was done. Search yielded 1,061 articles and after excluding articles based on the inclusion criteria, 37 articles were taken in to consideration. The review shows that differential SLT product has specific odds of oral carcinogenesis. Review also indicates the emerging data of cardiovascular risk due to higher use of SLT products along with its known cause of oral cancer. It also cautions about the adverse consequences of pregnancy associated with SLT use.

show abstract

Dumansız Tütün "Maraş Otu"nun Homosistein ve Kardiyovasküler Risk Parametreleri Üzerine Etkileri

Baylan

YARAR²,

CANSUN

et al. 2023

Sakarya Medical Journal

View full text Add to dashboard Cite

Objective: This study aims to investigate the relationship between smokeless tobacco (Maras powder) and cigarette consumption with homocysteine, Paraoxonase-1 (PON-1), Arylesterase (ARE), and Lipoprotein-a (Lp (a)), which are known as risk factors for cardiovascular diseases. Material and Methods: The individuals included in the study were divided into three groups as Maras powder users (n = 38), cigarette smokers (n = 38), and healthy volunteers who did not use either tobacco group (n = 38). Serum homocysteine, PON-1, ARE, and Lp (a) levels of all participants were examined. Results: When the groups are compared, the highest homocysteine level was in the Maras powder group. While the difference between the control group and the Maras powder group was statistically significant, the difference between the control and smokers groups was statistically insignificant. Although PON values were lower in both the Maras powder and smokers groups than the control group, the difference was significant only in the smoking group. ARE was significantly lower, and Lp (a) was significantly higher in both tobacco smokers groups compared to the control group. Conclusion: Serum homocysteine, PON-1, ARE, and Lp (a) level are associated with Maras powder use. Homocysteine may be a useful early marker for cardiovascular disease in those who use Maras powder.

show abstract

Smokeless tobacco: Risk factor for cardiovascular and breathing in young Indian adolescent

Cited by 4 publications

References 34 publications

Effectiveness of Behavioral Counseling in Smokeless Tobacco Cessation Among Adult Users Reporting to a Dental Hospital in Pune: A Randomized Controlled Trial

Effectiveness of Behavioral Counseling in Smokeless Tobacco Cessation Among Adult Users Reporting to a Dental Hospital in Pune: A Randomized Controlled Trial

Smokeless Tobacco and Its Ill-Effects: Recent Literature Update

Dumansız Tütün "Maraş Otu"nun Homosistein ve Kardiyovasküler Risk Parametreleri Üzerine Etkileri

Contact Info

Product

Resources

About